|
Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes
|
Aug 2012
|
Am J Hematol
|
myelodysplastic syndromes (MDS)
|
|
Myelodysplastic syndromes: 2012 update on diagnosis, risk-stratification, and management
|
Jul 2012
|
Am J Hematol
|
myelodysplastic syndromes (MDS)
|
|
Prediction of adverse events during Intensive Induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes
|
Jan 2014
|
Am J Hematol
|
myelodysplastic syndromes (MDS)
|
|
The phenotype of a germline mutation in PIGA: the gene somatically mutated in paroxysmal nocturnal hemoglobinuria
|
Feb 2012
|
Am J Hum Genet
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
The value of survival gains in myelodysplastic syndromes.
|
Jan 2017
|
Am J Manag Care
|
myelodysplastic syndromes (MDS)
|
|
Clinical presentation, diagnosis, and prognosis of myelodysplastic syndromes
|
Jul 2012
|
Am J Med
|
myelodysplastic syndromes (MDS)
|
|
Commentary on "myelodysplastic syndromes: challenges to improving patient and caregiver satisfaction"
|
Jul 2012
|
Am J Med
|
myelodysplastic syndromes (MDS)
|
|
Myelodysplastic syndromes: challenges to improving patient and caregiver satisfaction
|
Jul 2012
|
Am J Med
|
myelodysplastic syndromes (MDS)
|
|
Commentary on "myelodysplastic syndromes: therapy and outlook"
|
Jul 2012
|
Am J Med
|
myelodysplastic syndromes (MDS)
|
|
Epidemiology of myelodysplastic syndromes
|
Jul 2012
|
Am J Med
|
myelodysplastic syndromes (MDS)
|
